Need professional-grade analysis? Visit stockanalysis.com
$3.73B
N/A
124
N/A
4DMEDICAL Ltd (4DX) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at AUD5.84, down 8.75% from the previous close.
Over the past year, 4DX has traded between a low of AUD0.23 and a high of AUD6.80. The stock has gained 2063.0% over this period. It is currently 14.1% below its 52-week high.
4DMEDICAL Ltd has a market capitalization of $3.73B.
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
Side-by-side comparison against top Healthcare peers.